Creative Diagnostics advances IgM diagnostic testing with human hybrid monoclonal antibodies
Creative Diagnostics has launched a comprehensive range of human hybrid IgM control monoclonal antibodies designed to overcome critical challenges in diagnostic assay development. The new product line addresses the persistent difficulty of sourcing reliable IgM-positive control materials for infectious disease testing across multiple pathogens including CMV, HSV, measles, mumps, rubella, and varicella-zoster virus.


